<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>11707232</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Heras, M</dc:author>
<dc:type>Comment</dc:type>
<dc:language>es</dc:language>
<dc:date>2001 Nov </dc:date>
<dc:title xml:lang="es">Se debe controlar el tratamiento con los bloqueadores de la glucoprote√≠na IIb/IIIa en el intervencionismo coronario?</dc:title>
<dc:title xml:lang="en">[Should treatment with glycoprotein IIa/IIIb receptor blocker be controlled in patients undergoing coronary intervention?].</dc:title>
<dc:publisher>Revista espanola de cardiologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
